Home › Lipoid Nephrosis › North Carolina › Durham
Lipoid Nephrosis clinical trials in Durham, NC
4 studies for Lipoid Nephrosis are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
RecruitingPhase 2
- UNC Kidney Center- Site Number : 8400021, Chapel Hill · 10 mi away
NEPTUNE Match Study
Recruiting
- University of North Carolina Chapel Hill, Chapel Hill · 10 mi away
Nephrotic Syndrome Study Network
RecruitingObservational study
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
RecruitingPhase 2
- Duke Molecular Physiology Institute, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
Lipoid Nephrosis trials in other cities
- Philadelphia, PA5 studies
- Queens, NY5 studies
- Ann Arbor, MI5 studies
- Houston, TX4 studies
- Atlanta, GA4 studies
- Seattle, WA3 studies
- Los Angeles, CA3 studies
- Kansas City, MO3 studies
- New York City, NY3 studies
- Cleveland, OH3 studies
- Chicago, IL3 studies
Other studies in Durham
- Breast Cancer63 studies
- Cancer (all types)59 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Metastatic Cancer33 studies
- Acute Myeloid Leukemia33 studies
- Lung Cancer32 studies
- Prostate Cancer32 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Chronic Lymphocytic Leukemia27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.